Scientific deep-dive
Eating Too Little on a GLP-1: What the Deficiency Data Show
Across 480,825 adults, more than 60% took in less calcium and iron than their estimated requirements, vitamin D deficiency reached 13.6% at a year, and ferritin ran 26–30% below an active comparator.
The drug is supposed to make you eat less, and it does: three weeks into one tirzepatide trial, people ate about 525 fewer calories at a single lunch than those on placebo. The problem is that the drug does not distinguish between eating less and eating badly, and the evidence suggests most people end up doing both. Across six studies covering 480,825 adults, calcium and iron intake fell below estimated requirements in more than 60% of GLP-1 users, vitamin D deficiency reached 13.6% by twelve months, and ferritin ran 26–30% below an active comparator.[1]
Why appetite suppression does this
Three mechanisms stack, and the review names all three: appetite suppression, delayed gastric emptying, and altered absorption.[1] Eating less means less of everything. The body does not preferentially discard the calories you did not need.
There is a second, subtler problem. When appetite is low, the foods people keep are usually the easy ones. Protein-dense and fiber-dense foods feel heaviest and get dropped first, which is exactly backwards for anyone trying to protect muscle and bowel function while losing weight. Snacks compared by protein per calorie shows which small foods close that gap.
What is actually running low
| Finding | Detail |
|---|---|
| Calcium and iron intake below estimated requirements | More than 60% of users |
| Vitamin D deficiency | 7.5% at six months, rising to 13.6% at twelve |
| Iron status | Ferritin 26–30% lower than SGLT2 inhibitor comparators |
The iron figure matters because of its comparison group. These users were measured against people taking a different drug for the same conditions, not against the healthy general population, and that strips out a lot of confounding. A 26–30% gap in that comparison is harder to explain away, though the review notes its findings are mainly observational and cannot establish that the drug caused them.[1]
Low iron and low vitamin D both produce fatigue, which is one reason our fatigue article lists them as the first things to check before assuming the drug is doing it directly.
The rare end, and why it is here
Wernicke encephalopathy is acute brain injury caused by thiamine deficiency. It presents with confusion, abnormal eye movements and unsteadiness, it is a medical emergency, and it is largely reversible if treated quickly but not if treatment is delayed.
A 2025 analysis gathered a case in a 49-year-old woman on semaglutide alongside eighteen others from the literature and the World Health Organization’s VigiBase, and ran a disproportionality analysis. Wernicke encephalopathy was disproportionately reported with semaglutide, with tirzepatide, and with the GLP-1 class as a whole. In 68% of cases there was vomiting or reduced food intake, with weight loss running from 3.5 to 13.3 kg per month.[2]
In 68% of the nineteen reported cases, there was vomiting or reduced food intake.
Nineteen cases against many millions of prescriptions makes this rare. It is included here because thiamine deficiency is cheap to prevent, because the risk factors are the ordinary side effects of the drug and nothing exotic, and because the authors describe their own finding as a safety signal requiring prompt assessment.[2]
How much weight loss is too fast
The Wernicke cases ran between 3.5 and 13.3 kg a month.[2] For context, the pivotal trials averaged roughly 15% of body weight over 68 weeks, a far slower rate. Losing weight much faster than the trials did usually reflects intake low enough to matter, not a drug working better.
Rapid loss also drives other risks: gallstones, where the label notes the excess persisted even after adjusting for how much weight came off, and loss of lean mass.
What to do about it
- Eat to a target, not to appetite. Appetite is the thing the drug has switched off, which makes it a broken instrument for deciding how much to eat. Our protein and fiber calculators give numbers to aim at.
- Ask for blood work instead of assuming. Vitamin D, ferritin and B12 are cheap, routine, and the ones this evidence points at.
- Treat persistent vomiting as urgent rather than expected. It is the common thread in the severe cases, and it also drives the dehydration behind the acute kidney injury the label warns about.
- Do not assume a supplement covers it. A multivitamin is reasonable, but no trial has shown which regimen prevents these specific deficiencies on these specific drugs, and a prescriber who measures beats a guess.
Frequently Asked Questions
References
- 1.Urbina J, Salinas-Ruiz LE, Valenciano C, et al. Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrative Review Clinical Obesity. 2026. PMID: 41549912.
- 2.Gras C, De Wit V, Oussedik N, et al. Semaglutide-induced Wernicke encephalopathy: a comprehensive analysis European Journal of Clinical Nutrition. 2025. PMID: 40908328.
Compare the sellers
Related research
GLP-1 Drugs and Rheumatoid Arthritis: One Study, and What It Cannot Tell You
A retrospective review of 215 patients found greater falls in disease activity and pain among those who took a GLP-1 than among those prescribed one who did not. Nearly a third stopped the drug within the year.
6 min read
GLP-1 Drugs and Suicidal Thoughts: The Warning Came Off in 2026
In February 2026 the Suicidal Behavior and Ideation section was removed from the Wegovy, Zepbound and Saxenda labels, after three large studies looked for a signal and none found one.
7 min read
Phentermine and a GLP-1 Together: What the Labels and Trials Show
Phentermine's label says combining it with any other weight-loss drug is not recommended; the Wegovy and Zepbound labels never mention it. The one trial, with liraglutide, found no meaningful extra loss. No semaglutide or tirzepatide trial exists.
10 min read
Metformin and a GLP-1 Together: The Risk Is Not the One People Expect
The diabetes trials behind these drugs were largely run on people already taking metformin. Stomach side effects did not stack in the largest analysis, and low blood sugar comes from other drugs. The real overlap is dehydration.
8 min read
Ozempic and the Vagina: Dryness, Odor and Yeast Infections
No GLP-1 label lists a vaginal side effect. Genital yeast infections belong to SGLT2 diabetes drugs such as Jardiance, and GLP-1 users had fewer of them in cohort studies. What FDA reports show, likely causes of dryness and odor, and when to see a clinician.
11 min read
Holding a GLP-1 Before Endoscopy or Surgery: What the Trial Found
A 2026 randomized trial put retained stomach contents at 3.1% when one dose was held against 25.0% when it was not, and found something more useful about the day-before diet.
7 min read
Where to get tirzepatide online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Embody
From $129/mo
Get started →Collective
From $69/mo + membership
Get started →MyDrHank
An oral route if you will not self-inject
From $349/mo
Get started →